The German pharmaceutical excipient market is estimated to grow at a CAGR of 6.3% during the forecast period. Germany is the largest contributing country to the European market with a significant growth rate. The market growth in the country is driven by the increasing demand for pharmaceutical and biopharmaceutical drugs in the region. Further, the presence of a large number of biotech companies in the country drives the growth of the market.
To Request a Sample of our Report on Germany Pharmaceutical Excipient Market: https://www.omrglobal.com/request-sample/germany-pharmaceutical-excipient-market-growth-analysis
As per Germany Trade & Invest, there are around 679 dedicated biotechnological companies in the country whereas 141 other biotechnology-active companies in 2018. Around $1.3 billion was invested in R&D activities in the country. Some of the major companies include 3B Pharmaceuticals GmbH, BioChem Adda, BioNTech, Glycotope, and others.
In 2017, around 51% of the total drugs approved in the country were biopharmaceuticals and around 274 biopharmaceutical drugs were approved in the country which includes vaccines, monoclonal antibodies, and insulin. The high number of approvals of drugs in the country represents its increasing demand. This, in turn, supports the growth of the German pharmaceutical excipient industry.
Further, increasing R&D activities in the country also support market growth. For instance, in June 2017, the German Association for Synthetic Biology (GASB) was established in the country with an aim to augment research activities in the field of synthetic biology in the country. Some of the major synthetic biology labs operating in the country include the Institute of Applied Microbiology, Berlin Institute of Technology, Ansbach University of Applied Sciences, and others.
(Get 15% Discount on Buying this Report)
A full Report of Germany Pharmaceutical Excipient Market is Available at: https://www.omrglobal.com/industry-reports/germany-pharmaceutical-excipient-market-growth-analysis
Market Coverage
- Market number available for – 2018-2025
- Base year- 2018
- Forecast period- 2019-2025
- Segment Covered- By Product and By Formulation Type
- Regions Covered- Germany
- Competitive Landscape- Merck KGaA, DFE Pharma, BASF SE, Roquette Freres SA, and Meggle AG.
German Pharmaceutical Excipient Market- Segmentation
By Products
- Solubilizers & Surfactants/Emulsifiers
- Polyols
- Carbohydrates
- Specialty Excipients
By Formulations
- Oral Formulations
- Topical Formulations
- Parenteral Formulations
- Other Formulations
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
